jenefa begum Profile
jenefa begum

@JenefaBegum

Followers
92
Following
649
Media
2
Statuses
35

PhD student at the University of Birmingham, Institute of cardiovascular sciences, Leukocyte trafficking group | Foam cells, Macrophages and Autophagy

England, United Kingdom
Joined February 2020
Don't wanna be here? Send us removal request.
@DrAJIqbal
AJIqbal Lab
4 months
Proud PI moment @JenefaBegum congratulations on graduating with your PhD- super proud of you!
1
2
12
@DrAJIqbal
AJIqbal Lab
1 year
Check out the latest study from @McGettrickLab Therapeutic avenues in bone repair: Harnessing an anabolic osteopeptide, PEPITEM, to boost bone growth and prevent bone loss: Cell Reports Medicine
Tweet card summary image
cell.com
Lewis and Frost et al. identify the anabolic activity of an endogenous osteopeptide (PEPITEM), revealing the cellular and molecular mechanisms by which PEPITEM regulates bone remodeling in vitro and...
0
2
11
@DrAJIqbal
AJIqbal Lab
2 years
Our latest collaborative effort with @immuno_pharma published in J of Autoimmunity A reverse translational approach reveals the protective roles of Mangi...
0
1
6
@DrAJIqbal
AJIqbal Lab
2 years
We have a 3 year fully funded BHF postdoc position available, please apply!
@JulieRayes
Julie Rayes
2 years
Interested in platelets? A great opportunity to join @DrAJIqbal lab to investigate the role of galectin-9 in thrombo-inflammation, from in vitro to in vivo models! An exciting collaboration with @AlexanderBrill8 and myself @ICVS_UoB @TheBHF https://t.co/WWMapWG7j3
0
5
12
@JenefaBegum
jenefa begum
2 years
I had the fantastic opportunity of co-chairing the final plenary session for @bsicongress in belfast today thanks to @McGettrickLab and @DrAJIqbal for the possibility to attend #BSI23
1
2
16
@BirminghamBRC
NIHR Birmingham Biomedical Research Centre
2 years
BRC researchers @DrAJIqbal, @TariqFMT & @McGettrickLab are partnering with @Roche to investigate how inflammatory bowel disease (#IBD) develops in relation to the types of macrophages in the intestine, with a view to developing new treatments for patients: https://t.co/chx8abtOUF
0
9
17
@DrAJIqbal
AJIqbal Lab
2 years
A wonderful collaboration with @immuno_pharma @McGettrickLab @ADILABOMANSOUR1 @JenefaBegum so many fantastic colleagues. Really looking forward to continuing this exciting work!
@immuno_pharma
ImmunoPharmaLab
2 years
Il-17 story. Today our scientific work has just been accepted by the J An.of the RheDis(IF:27.5) in which a new biologic (Ab-IPL-IL17™) for IL-17-mediated diseases has been characterized by our group. It's a small step toward identifying innovative therapies for Autoim.Diseases
1
4
11
@immuno_pharma
ImmunoPharmaLab
2 years
Il-17 story. Today our scientific work has just been accepted by the J An.of the RheDis(IF:27.5) in which a new biologic (Ab-IPL-IL17™) for IL-17-mediated diseases has been characterized by our group. It's a small step toward identifying innovative therapies for Autoim.Diseases
0
3
9
@DrAJIqbal
AJIqbal Lab
2 years
Check out our latest work! @Chimen_lab @McGettrickLab @ICVS_UoB Aging modulates homeostatic leukocyte trafficking to the peritoneal cavity in a sex-specific manner
Tweet card summary image
academic.oup.com
Abstract. Aging is associated with exacerbated systemic inflammation (inflammaging) and the progressive loss of immune system function (immunosenescence).
0
5
15
@CVS_UoB
Cardiovascular Sciences (CVS)- UoB
3 years
Research shows the peptide called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related diseases: https://t.co/2iWW9woXRO. Read the paper: https://t.co/OJiBjP28CD @news_UB @unibirm_MDS @InflamAge_UoB @DrAJIqbal #obesity
academic.oup.com
In this manuscript, we demonstrate for the first time that therapeutic administration of the immunopeptide, PEPITEM, limits the pathological impact of obes
0
2
0
@JulieRayes
Julie Rayes
3 years
Many thanks to @GinaPerrella @PlateletVienna @nikmutch @PipNicolson @AbAttacks @SikhScientist @JoanneClark04 @DrAJIqbal @JenefaBegum @JoshuaHBourne @HarryZhi3 @SimpsonMegan8 and many others not on twitter for their help during very challenging times!
0
2
15
@JulieRayes
Julie Rayes
3 years
Happy to share our most recent study⁩ lead by ⁦@MIDASUoB⁩ PhD student ⁦@MartinaColicch3⁩ and a team effort from ⁦@bhamplateletgrp⁩ ⁦@ICVS_UoB⁩ and amazing collaborators⁩, funded by ⁦@wellcometrust⁩ & ⁦⁦@TheBHF
12
21
76
@DrAJIqbal
AJIqbal Lab
3 years
Proud PI moment, congratulations @ADILABOMANSOUR1 on your poster prize at BHF Accelerator symposium @TheBHF @ICVS_UoB
4
3
23
@DrAJIqbal
AJIqbal Lab
3 years
Having a fantastic time at 15th WCI, lots of interesting science and wonderful to see so many colleagues F2F! @immuno_pharma @ICVS_UoB
0
3
11
@DrAJIqbal
AJIqbal Lab
3 years
Students presenting posters at WCI, well done to all! @ICVS_UoB @McGettrickLab
0
3
16
@poppynathan
Poppy Nathan
3 years
What a way to end an amazing few days! Very honoured to have recieved an Oral Communications Award for my (first ever!) conference talk. Very proud of @JenefaBegum and @Yeebba1 for winning Poster Awards - big wins for #LeukocyteTraffickingGroup @ICVS_UoB @InflamAge_UoB #wci2022
5
5
28
@poppynathan
Poppy Nathan
3 years
Day 2 of #wci2022 and #leukocytetraffickinggroup smashed it again. Really engaging talk by @Jools857 and poster by @Yeebba1 👏👏👏
0
3
15
@McGettrickLab
Helen McGettrick
3 years
@poppynathan @hopkin_sj presenting their first oral communication at #WCI2022ROME. Thanks to @britsocimm for the travel award that made this happen. @InflamAge_UoB @ICVS_UoB @UoBGradSchool @MIDASUoB @royalsociety
0
3
8
@CR_UK
Cancer Research UK
5 years
Wishing a happy and peaceful #Ramadan to everyone observing the holy month – Ramadan Mubarak!
1
17
50
@JenefaBegum
jenefa begum
5 years
Its good to be back, finally!☺️ #backtolabs #COVID19 #phdlife
1
0
10